These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. [The correlation between hematopoietic status of the bone marrow and peripheral or marrow reticulocyte classification by using the automated reticulocyte analyzer Sysmex R-3000]. Kageoka T; Kanekuni Y; Fujita T; Ikeda H; Yamasaki K Rinsho Byori; 1992 Jun; 40(6):595-601. PubMed ID: 1513031 [TBL] [Abstract][Full Text] [Related]
13. Immature platelet fraction for prediction of platelet engraftment after allogeneic stem cell transplantation. Takami A; Shibayama M; Orito M; Omote M; Okumura H; Yamashita T; Shimadoi S; Yoshida T; Nakao S; Asakura H Bone Marrow Transplant; 2007 Apr; 39(8):501-7. PubMed ID: 17334382 [TBL] [Abstract][Full Text] [Related]
14. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation. Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941 [TBL] [Abstract][Full Text] [Related]
15. Automated immature reticulocyte counts are early markers of engraftment following autologous PBSC transplantation in patients with lymphoma. George P; Wyre RM; Bruty SJ; Sweetenham JW; Duncombe AS J Hematother Stem Cell Res; 2000 Apr; 9(2):219-23. PubMed ID: 10813535 [TBL] [Abstract][Full Text] [Related]
16. [A pilot study of G-CSF mobilized allogeneic bone marrow cells plus peripheral blood stem cells transplantation for malignant hematological diseases]. Chen Y; Huang X; Xu L; Liu D; Zhang Y; Ren H; Guo N; Lu D Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(19):1306-9. PubMed ID: 12509932 [TBL] [Abstract][Full Text] [Related]
17. Criteria for marrow engraftment: comparison of reticulocyte maturity index with conventional parameters. Dalal BI; Stockford GR; Naiman SC; Spinelli JJ; Phillips GL Bone Marrow Transplant; 1996 Jan; 17(1):91-2. PubMed ID: 8673062 [TBL] [Abstract][Full Text] [Related]
18. Delayed administration of G-CSF until day +7 after autologous peripheral blood stem cell transplant is as effective in accelerating hematopoietic as day 0. Sobrevilla-Calvo P; Zinser Sierra JW; Lara Medina FU; Acosta Barreda A; Calderón Flores E Rev Invest Clin; 2002; 54(1):51-6. PubMed ID: 11995407 [TBL] [Abstract][Full Text] [Related]
19. [Evaluation of hematopoiesis by granulocyte elastase after hematopoietic stem cell transplantation]. Miyajima T; Itoh T; Simojima H; Hatta Y; Sawada U; Horie T Rinsho Ketsueki; 2000 Apr; 41(4):316-21. PubMed ID: 10846462 [TBL] [Abstract][Full Text] [Related]
20. Low-dose non-glycosylated rhGM-CSF is effective for the treatment of delayed hematopoietic recovery after autologous marrow or peripheral blood stem cell transplantation. Ippoliti C; Przepiorka D; Giralt S; Andersson BS; Wallerstein RO; Gutterman J; Deisseroth AB; Champlin RE Bone Marrow Transplant; 1993 Jan; 11(1):55-9. PubMed ID: 8094309 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]